Ergomar side effects by duration, gender and age - a phase IV clinical study of FDA data


Side effects are reported by people who take Ergomar. Common side effects include drug hypersensitivity among females, and drug ineffective among males.

The phase IV clinical study is created by eHealthMe based on 31 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 20, 2023

31 people who take Ergomar and have side effects are studied.

What is Ergomar?

Ergomar has active ingredients of ergotamine tartrate. Currently, eHealthMe is studying from 32 Ergomar users.

Number of Ergomar reports submitted per year:

Ergomar side effects.

Ergomar side effects by gender *:


  1. Drug hypersensitivity
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Blood creatine phosphokinase increased
  5. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)


  1. Drug ineffective
  2. Renal infarct (kidney damage due to lack of blood supply)

Ergomar side effects by age (0-1 to 60+) *:










  1. Blood creatine phosphokinase increased




  1. Drug hypersensitivity
  2. Renal infarct (kidney damage due to lack of blood supply)
  3. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)


  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Drug ineffective

* Approximation only. Some reports may have incomplete information.

Do you take Ergomar?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on ergotamine tartrate (the active ingredients of Ergomar) and Ergomar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Ergomar:

All Ergomar side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: